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Objectives: Antibiotic use is unnecessarily high for paediatric respiratory tract infections (RTIs) in primary care,
and implementation of treatment guidelines is difficult in practice. This study aims to assess guideline adherence
to antibiotic prescribing for RTIs in children and examine potential variations across Dutch general practices.
Methods:We conducted a retrospective observational study, deriving data on diagnoses and prescriptions from
the electronic health records-based NIVEL Primary Care Database. Patients,18 years of age with a diagnosis of
fever, ear and respiratory infections (International Classification of Primary Care codes A03, H71, R72, R75, R76,
R78 and R81) during 2010–12 were included. Antibiotics were linked to episodes of illness. Two types of disease-
specific outcomes were used to assess adherence to national guidelines regarding antibiotic prescribing choices.
Inter-practice variability in adherence was assessed with multilevel analysis.
Results: Half of the episodes with RTIs with restrictive prescribing policy and 65% of episodes with pneumonia
were treated with antibiotics. General practitioners prescribed antibiotics for 40% of episodes with bronchitis,
even though guidelines discourage antibiotic prescribing. First-choice antibiotics were prescribed in 50%–85%
of episodes with selected diseases, with lowest values for narrow-spectrum penicillins. Levels of adherence to
guidelines varied widely between diagnoses and between practices.
Conclusions: Most paediatric RTIs in the Netherlands continue to be treated with antibiotics conservatively.
Potential aspects of concern are the inappropriate antibiotic prescribing for acute bronchitis and the underuse
of some first-choice antibiotics. Continuing progress may be achieved by targeting practices with lower adher-
ence rates to guidelines.
Introduction
Over 80% of antibiotics in developed countries are prescribed in pri-
mary care,mainly for respiratory tract infections (RTIs).1,2Antibiotic
treatments are often unnecessary, as a majority of RTIs are viral
and self-limiting.3–6 Antibiotic use is especially high among chil-
dren, and up to a third of their consultations for RTIs in primary
care result in an antibiotic prescription.7,8 This high prescription
rate is probably based on concerns about children’s susceptibility
to bacterial infections and development of secondary complica-
tions, even though only a small number of themare at such risk.9,10
In response, numerous efforts to optimize antibiotic prescrib-
ing have been ongoing with mixed success.11–13 Since the late
1990s, an overall decrease in antibiotic prescription rates for chil-
dren has been reported in Europe and the USA, but prescription
rates seem to have stabilized now.14–17
Clinical practice guidelines have increasingly been used to sup-
port physicians in their decision whether or not to prescribe anti-
biotics and which antibiotics to prescribe.18 However, the
implementation of treatment guidelines for antibiotic prescribing
has proved to be difficult in practice.19,20 Moreover, available
evidence has shown marked differences in adherence rates to
guidelines across paediatric respiratory and ear infections and
substantial variations by practice.21,22
A country that has maintained a comparatively low and stable
antibiotic use in primary care over the years, with antimicrobial
resistance rates that are among the lowest in Europe, is the
Netherlands.23,24 The Dutch College of General Practitioners
(NHG) produces and updates evidence-based guidelines.25–29 To
facilitate the decision-making process in daily practice, NHG pre-
scribing advice is included in the physicians’ software as electronic
prescription decision support.
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Guidelines are generally accepted and used by Dutch general
practitioners (GPs), but recent research on antibiotic use in the
adult population has revealed two potential aspects of concern.
Firstly, most antibiotics have been prescribed for uncomplicated
RTIs. Secondly, 20%–30% of antibiotic prescriptions have not
been for the recommended first-choice antibiotics.30,31 Similar
issues were highlighted in children during earlier evaluations of
adherence to RTI guidelines between 1998 and 2008.32,33
However, recent studies that measure GPs’ adherence to guide-
lines for antibiotic prescribing in Dutch children and its variation
across practices are not available. Our study objectives were to
assess guideline adherence to antibiotic prescribing in paediatric
fever and ear and respiratory infections in the Netherlands, in
terms of both the degree of prescribing per diagnosis and the choice
of antibiotics. In addition, we intended to examine potential varia-
tions in guideline adherence across different general practices.
Methods
Datasets and study population
Our data were derived from the NIVEL Primary Care Database (NPCD),
which collects data from routine electronic health records of a large and
dynamic pool of general practices across the Netherlands.34
The participating practices are representative of the Dutch GP popula-
tion regarding type of practice (single-handed/group), urbanization level
and region. The population covered has similar demographic characteris-
tics to the national Dutch population. The database includes information
on patient gender, year of birth, dates of consultation and clinical diagno-
ses, which are coded using the International Classification of Primary Care
version 1 (ICPC-1) scheme.35 In addition, information on prescriptions by
physicians is available, coded according to the Anatomical Therapeutic
Chemical (ATC) Classification Index.36
Practices were included in the study on a per-year basis if at least
70% of consultations included a registered diagnosis, and prescription
and morbidity data were registered for at least 46 weeks of the year.
Our study population consisted of all patients from these practices
,18 years of age who were diagnosed by their GP with fever or ear or
respiratory infection, and had a database history of at least one quartile
of a year in 2010, 2011 or 2012. The study was carried out according to
Dutch legislation on privacy.37 The privacy regulation of the NPCD was
approved by the Dutch Data Protection Authority. According to Dutch
legislation, obtaining informed consent and/or approval by medical ethics
committee is not obligatory for observational studies.
Study definitions
First, we matched the ICPC codes used in the database to clinical condi-
tions as specified in the NHG guidelines.25–29 Seven ICPC codes were suf-
ficiently specific to the diseases described in the guidelines to be included
in our analysis: fever (A03); acute otitis media (AOM; H71); strep throat/
scarlet fever (R72); sinusitis acute/chronic (R75); acute tonsillitis (R76);
acute bronchitis/bronchiolitis (R78); and pneumonia (R81). The wider
group of upper RTIs (R74) was not included in our study as there are no
specific Dutch guidelines for children on these health conditions. Acute
cough (R05) was also excluded, since children’s cough may in general be
associated with a broader array of conditions other than acute RTIs.
Our analysis was based on constructed episodes of illness that
included all the consultations concerning the same health problemwithin
a pre-set time frame. The algorithm used is described elsewhere.38
The antibiotics in the study were defined as antibacterials for systemic
use (ATC code J01). They were linked to the episodes of illness using pre-
scription date and episode start and stop date. This enabled us to deter-
mine whether and which antibiotics were prescribed for a specified
diagnosis. In case more than one antibiotic was prescribed during an epi-
sode, we used the first prescription for analysis.
We used two types of disease-specific outcomes to examine discrep-
ancies between clinical practice and national recommendations for anti-
biotic prescribing in children during 2010, 2011 and 2012.39,40 The first
type of outcomemeasured guideline adherence on whether or not to pre-
scribe antibiotics for the diagnosis. The second type of outcome evaluated
the kind of antibiotic prescribed, and was used for the five diagnoses that
require antibiotic use according to guidelines (H71, R72, R75, R76 and R81).
Table 1 summarizes the recommendations of the NHG guidelines.
Lower values (closer to the minimum score) for the percentages of epi-
sodes of fever and bronchitis treated with antibiotics probably represent
greater adherence to guidelines. In contrast, higher values (closer to the
maximum score) for the percentages of episodes of pneumonia treated
with antibiotics may show greater adherence to guidelines. Appropriate
values for the percentages of episodes with restrictive antibiotic use
Table 1. Recommended antibiotic prescribing according to diagnosis by the NHG25–29
National guidelines Diagnosis and ICPC
Indication for antibiotic
prescription Recommended antibiotics
Fever fever (A03) no antibiotics in general none
AOM AOM (H71) restrictive antibiotic use 1st choice: amoxicillin (J01CA04)
2nd choice: azithromycin (J01FA10) or co-trimoxazole (J01EE01)
Acute sore throat strep throat/scarlet
fever (R72)
restrictive antibiotic use 1st choice: phenethicillin (J01CE05) or phenoxymethylpenicillin (J01CE02)
2nd choice: azithromycin (J01FA10)
if persists: amoxicillin/clavulanate (J01CR02) or clindamycin (J01FF01)
Rhinosinusitis sinusitis acute/
chronic (R75)
restrictive antibiotic use 1st choice: amoxicillin (J01CA04) or doxycycline (J01AA02)
2nd choice: azithromycin (J01FA10) or erythromycin (J01FA01)
Acute sore throat acute tonsillitis (R76) restrictive antibiotic use 1st choice: phenethicillin (J01CE05) or phenoxymethylpenicillin (J01CE02)
2nd choice: azithromycin (J01FA10)
if persists: amoxicillin/clavulanate (J01CR02) or clindamycin (J01FF01)
Acute cough acute bronchitis/
bronchiolitis (R78)
no antibiotics in general none
Acute cough pneumonia (R81) antibiotic use 1st choice: amoxicillin (J01CA04)
2nd choice: azithromycin (J01FA10)
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(AOM, strep throat, sinusitis and tonsillitis) might vary according to patient
age and casemix. The ideal level of appropriate prescribing is therefore not
known. However, lower scores probably represent greater adherence to
guidelines. Higher values for first-choice antibiotics represent greater
adherence to guidelines.
Analysis
We first calculated the annual incidence rates for each diagnosis per 1000
person-years in order to see the extent of the problem and to calculate
numerators.
The first group of indicators was computed by dividing the number of
ICPC episodes with an antibiotic prescription by the total number of epi-
sodes for that ICPC during that year. The second set of indicators was cal-
culated by dividing the number of ICPC episodes prescribed an antibiotic
with a specific ATC code by the total number of the ICPC episodes treated
with any antibiotic.
To assess inter-practice variability in guideline adherence to antibiotic
prescribing, multilevel logistic regression analysis (MLA) was performed for
both sets of indicators in 2012. We included only the first consultation for
illness for each ICPC and corrected the results for patient age and gender.
The size of variation between practices was illustrated by their 95% prac-
tice range, within which 95% of practices’ adherence falls. Values between
2.5% and 97.5% were used to exclude the bottom and top 2.5% of prac-
tices with extreme values, and thereby drop the outliers.
Data on disease episodes treated with antibiotics were analysed with
SPSS version 20.0 (SPSS Inc., Chicago, IL, USA), while the variability was
analysed using STATA version 13.1 (StataCorp LP, College Station, TX, USA).
Results
Overall, 68 general practices in 2010, 133 in 2011 and 101 in 2012
were included in this study. The total number of children being
diagnosed with the diagnoses of interest was 10717 in 2010,
22508 in 2011 and 13755 in 2012. Their gender and age distribu-
tion did not change substantially over the years: 51% of the
patients were boys and their mean age was around 6.8 years dur-
ing the study period. All incidence rates remained stable over time,
ranging from 3 per 1000 person-years for strep throat to around
75 per 1000 person-years for AOM (Table 2).
Figure 1 illustrates GPs’ adherence to recommendations on
whether or not to prescribe antibiotics for the selected diagnoses
during the period 2010–12. Among clinical conditions that require
antibiotics, highest antibiotic prescribing rates were seen in pneu-
monia cases (.65%), followed by strep throat and tonsillitis epi-
sodes (50%–60%) and AOMand sinusitis cases (,50%). For those
diagnoses where antibiotics are generally not recommended,
11% of fever cases and .40% of cases with acute bronchitis
were prescribed an antibiotic.
Table 3 provides an overview of guideline adherence to first-
choice antibiotics for diagnoses that require antibiotics. During
the period 2010–12, 85% of AOM cases were treated with first-
choice amoxicillin and 75% of sinusitis cases with doxycycline or
amoxicillin in accordance with guidelines. The recommended
antibiotic (amoxicillin) was prescribed in.60% of pneumonia epi-
sodes, while 20% received the non-recommended antibiotics
(amoxicillin/clavulanate or clarithromycin). Only 55%–65% and
50%–55% of strep throat and tonsillitis cases, respectively,
were prescribed first-choice narrow-spectrum penicillins, while
15%–31% of cases used the non-recommended amoxicillin.
Table 4 illustrates the variance in antibiotic prescribing accord-
ing to diagnosis between general practices for both restrictive
prescribing and choice of antibiotics. Among clinical conditions
that require antibiotics, the widest 95% practice range for
antibiotic prescribing rates were seen in children with strep
throat (16.8%–88.7%) and sinusitis (19.4%–77.2%), followed
by tonsillitis (30.7%–76.8%), pneumonia (40%–84%) and AOM
episodes (27.3–70%). Large variation in antibiotic prescribing
was also found in bronchitis (23.2%–70.1%), where antibiotics
are generally not recommended. Inter-practice variations in
adherence to first-choice antibiotics were larger compared with
variations in adherence to restrictive prescribing for most diagno-
ses. The practice variation in the use of first-choice antibiotics was
particularly marked in cases of tonsillitis (9.2%–83.3%), sinusitis
(29.5%–95.9%) and pneumonia (28%–90.5%).
Discussion
Summary
We found that about two-thirds of patients with pneumonia and
about half of the cases with AOM, strep throat, tonsillitis and
sinusitis were treated with antibiotics. GPs prescribed antibiotics
to .40% of children with acute bronchitis, which is not in
Table 2. Number of episodes and incidence rates (cases/1000 person-years) of fever and ear and respiratory infections during 2010–12
Clinical condition (ICPC) ICPC frequency 2010 2011 2012
Fever (A03) number of episodes (% of all cases) 2511 (23.4%) 5552 (25.3%) 3425 (24.9%)
incidence rates 39.8 44.7 41.9
AOM (H71) number of episodes (% of all cases) 4239 (39.5%) 8365 (38.1%) 5547 (40.3%)
incidence rates 75.1 73.5 76.8
Strep throat (R72) number of episodes (% of all cases) 192 (1.8%) 347 (1.6%) 187 (1.4%)
incidence rates 3.3 3.1 3.4
Sinusitis (R75) number of episodes (% of all cases) 437 (4.1%) 795 (3.6%) 510 (3.7%)
incidence rates 8.1 7.3 7.1
Tonsillitis (R76) number of episodes (% of all cases) 1206 (11.3%) 2461(11.2%) 1543 (11.2%)
incidence rates 21.3 22.1 22.1
Bronchitis (R78) number of episodes (% of all cases) 1510 (14.1%) 2913 (13.3%) 1716 (12.5%)
incidence rates 27.2 26.8 24.9
Pneumonia (R81) number of episodes (% of all cases) 622 (5.8%) 1551 (7.1%) 827 (6%)
incidence rates 10.8 13.7 11.7
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accordance with guidelines. Between 15% and 50% of cases with
any of the diagnoses were not prescribed their first-choice antibio-
tics, with adherence being particularly low for narrow-spectrum
penicillins. The large inter-practice variations in antibiotic use indi-
cate there is room for improvement with regard to choice of type
and indication of antibiotics.
Strengths and limitations
The main strength of our study is that the data come from a large
nationwide database, using individual patient records. We were
able to link the information on antibiotics to the diagnosis,
which helps identify inappropriately treated infections. We report
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Figure 1. Percentages of infection episodes treated with antibiotics during the period 2010–12.
Table 3. Choice of antibiotics for episodes of ear infections and RTIs recommended to be treated with antibiotics 2010–12
Diagnosis (ICPC) Antibiotic use 2010 (%) 2011 (%) 2012 (%)
AOM (H71) in line with 1st choice 84.4 85.7 86
in line with 2nd choice 4.5 5.8 5.9
in line with 1st or 2nd choice 88.9 91.5 91.9
amoxicillin/clavulanate (J01CR02) 7.1 4.8 5.1
clarithromycin (J01FA09) 2.8 2.8 2
Strep throat (R72) in line with 1st choice 54.5 64.5 64.4
in line with 2nd choice 9.8 13.2 7.7
in line with 3rd choice 4.9 3.6 5.8
in line with 1st, 2nd or 3rd choice 69.1 81.2 77.9
amoxicillin (J01CA04) 22.8 14.7 16.4
Sinusitis (R75) in line with 1st choice 77.9 79 74.8
in line with 2nd choice 7.1 8.8 12.8
in line with 1st or 2nd choice 85 87.7 87.6
clarithromycin (J01FA09) 7.1 5.7 4
amoxicillin/clavulanate (J01CR02) 6.3 4.7 6.8
Tonsillitis (R76) in line with 1st choice 54.6 53.9 49.9
in line with 2nd choice 6.8 6.6 7.2
in line with 3rd choice 6.3 6.3 6.7
in line with 1st, 2nd or 3rd choice 67.7 66.8 63.9
amoxicillin (J01CA04) 25.8 27.6 31.4
Pneumonia (R81) in line with 1st choice 60.4 66.9 63
in line with 2nd choice 9.8 8.5 13.3
in line with 1st or 2nd choice 70.2 73.4 76.3
amoxicillin/clavulanate (J01CR02) 14.1 12.8 12
clarithromycin (J01FA09) 8.6 6.6 7.3
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episode-based antibiotic prescription rates, which may affect
comparability with studies that applied different definitions,
such as contact-based rates, or used a distinct episode construc-
tion. Nevertheless, RTIs are often acute, short-term diseases for
which patients contact the GP only once (as was the case in
74% of our episodes in 2012), so the results are expected to be
comparable to contact-based outcomes.
This study was set in GP practices, and it assessed antibiotic
prescribing during office hours. Further research on guideline
adherence in Dutch out-of-hours (OOH) primary care service is
highly relevant to the provision of an overviewof national prescrip-
tion patterns for RTIs.
Our study has several limitations, which are inherent to the use
of electronic patient records. Firstly, earlier Dutch studies showed
that GPs that participated in NPCD had lower antibiotic prescribing
rates than other GPs in their region.1,41 The network has expanded
since then, and we expect that these differences have become
smaller.
The second potential bias might be related to GPs’ incomplete
or incorrect registration of diagnostic codes. The completeness
of GP diagnostic coding has greatly improved in recent years, as
much attention has been paid to improving routine registration
at the national level (such as use of the Electronic Patient
Dossier scan to measure the quality of registration, and reim-
bursement for good registration).42 However, it is possible that
coding differences could have contributed to the wide variation
by practice that we observed. If this is the case, a combination
of diagnostic codes and available clinical information at the
patient level will be an important next step to improve prescribing
quality assessment.
In this study no information was retrieved on patients’ disease
severity, risk factors for complications or inappropriateness of
first-choice antibiotics. Moreover, we did not investigate patients’
referral or hospitalization rates or GPs’ utilization of (rapid) diag-
nostic tests. Thesemissing details may restrict our ability to deter-
mine to what extent observed prescribing practices are justified
according to NHG guidelines. It is particularly difficult to set the
standards for restrictive prescribing in children. On the one
hand, Cochrane reviews suggest that most cases may resolve
without antibiotic treatment (82% of sore throats, 80% of acute
sinusitis and 78% of AOM).3–5 On the other hand, antibiotics can
be clinically indicated for many of these episodes on the basis of
illness severity, bacterial aetiology or a child’s age. Thus, other
studies from primary healthcare settings with a comparable
patient case mix may be useful to better interpret the measured
outcomes.
Comparison with existing literature
Our results show lower antibiotic use for paediatric tonsillitis and
sinusitis in the Netherlands compared with the period 2002–08,
when antibiotics were prescribed in 60% of such cases, while
Table 4. Inter-practice variations in paediatric antibiotic prescribing according to diagnosis in 2012
Diagnosis—ICPC Mean %
95% practice
range
Number of
practices
1. AOM (H71)
1a. percentage of H71 disease episodes prescribed antibiotics 48.4 27.3–70 101
1b. percentage of H71 disease episodes prescribed antibiotics receiving 1st-choice antibiotic 88.3 62.9–97.1 101
1c. percentage of H71 disease episodes prescribed antibiotics receiving 1st- or 2nd-choice antibiotics 93.7 70.7–98.9 101
2. Strep throat (R72)
2a. percentage of R72 disease episodes prescribed antibiotics 55.7 16.8–88.7 71
2b. percentage of R72 disease episodes prescribed antibiotics receiving 1st-choice antibioticsa 62.1 62.1–62.1 55
2c. percentage of R72 disease episodes prescribed antibiotics receiving 1st-, 2nd- or 3rd-choice antibioticsa 76.3 76.3–76.3 55
3. Sinusitis acute/chronic (R75)
3a. percentage of R75 disease episodes prescribed antibiotics 47.5 19.4–77.2 88
3b. percentage of R75 disease episodes prescribed antibiotics receiving 1st-choice antibiotics 75.8 29.5–95.9 80
3c. percentage of R75 disease episodes prescribed antibiotics receiving 1st- or 2nd-choice antibiotics 85.2 68.1–94 80
4. Acute tonsillitis (R76)
4a. percentage of R76 disease episodes prescribed antibiotics 54.8 30.7–76.8 100
4b. percentage of R76 disease episodes prescribed antibiotics receiving 1st-choice antibiotics 41.5 9.2–83.3 100
4c. percentage of R76 disease episodes prescribed antibiotics receiving 1st-, 2nd- or 3rd-choice antibiotics 59 14.2–92.6 100
5. Acute bronchitis/bronchiolitis (R78)
5a. Percentage of R78 disease episodes prescribed antibiotics 45.7 23.2–70.1 99
6. Pneumonia (R81)
6a. percentage of R81 disease episodes prescribed antibiotics 65.2 40–84 94
6b. percentage of R81 disease episodes prescribed antibiotics receiving 1st-choice antibiotics 65.8 28–90.5 87
6c. percentage of R81 disease episodes prescribed antibiotics receiving 1st- or 2nd-choice antibiotics 78.6 40.9–95.2 87
aLow patient numbers per practice (,10 patients per practice).
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prescribing rates of 50% for AOM stayed the same over time.33 A
recent analysis in the UK displayed a downtrend in the percentage
of sore throat episodes treated with antibiotics from 77% to 62%
during the 1990s and a tendency to stabilization afterwards,
though these levels are still higher than our results.19 UK percen-
tages of AOM cases linked with an antibiotic were broadly
unchanged over the period 1995–2011, with a mean of 83%,
which is far above our rates.20 International research illustrates
that antibiotic use for AOM ranged from 40% to 80% in Norway
and the USA, respectively, considering differences in national
recommendations and GP practices.43,44
In terms of acute bronchitis, we show that a comparable
number or fewer cases were treated with antibiotics than before
in the Netherlands (52%) and in comparison with other Western
countries: Norway (40%); the UK (48%); and the USA (60%–
80%).30,43,45,46 Such universally high rates of unnecessary
prescribing for bronchitis across all ages may imply that daily
practices have been substantially resistant to improvement.
Explanations may include diagnostic uncertainty about the pos-
sible presence of pneumonia, perceived patient (parental)
demand for antibiotics, or time pressure.47 Emerging evidence
shows that GPs with training in communication skills and access
to C-reactive protein near-patient tests wrote fewer antibiotic pre-
scriptions for acute cough.48,49 We do not know whether GPs in
our study used decision support tools to diagnose acute bronchitis
and wewere not able to look closely at patients’ characteristics to
understand the circumstances of such prescribing patterns.
Pneumonia was treated with antibiotics most frequently. Still,
up to 30% of cases did not receive antibiotics, which may raise
questions about whether such ‘under-treatment’ practices are
safe and unrelated to adverse outcomes. The results suggest
that GPsmay have restrained from empirical antibiotic prescribing
for suspected viral pneumonia. In addition, GPs may be less con-
fident about the diagnosis of complicated pneumonia in primary
care, and refer serious cases to hospital immediately. Treatments
not initiated by GPs are not included in the database, which might
lead to an underestimation of antibiotic use in pneumonia.
One Flemish study indicated that patients with pneumonia who
did not receive antibiotics were actually referred to the emergency
department by GPs working in OOH settings.50 This is probably
true for primary care during office hours as well, but we
were not able to investigate referrals or complication rates in
(un)treated pneumonia cases. Nonetheless, a similar antibiotic
prescription rate of 67% in paediatric pneumonia cases without
reported complications was found in Norway.43
About 40% of pneumonia cases were prescribed macrolides or
amoxicillin/clavulanate, instead of the first-choice antibiotic,
amoxicillin. Due to their broader spectrum of antibiotic coverage,
these antibiotics may have been considered a better choice for
patients with severe conditions, allergy to penicillin or the risk of
bacterial resistance. The estimated prevalence of patients’ allergy
to penicillins is 0.7%–8%, while the most common bacterial
pathogen of pneumonia in the Netherlands, Streptococcus
pneumoniae, is susceptible to penicillin (1%–3% of resistant
strains).51,52 However, high resistance to amoxicillin among
b-lactamase-producing Haemophilus influenzae (17% in 2010)
may necessitate other antibiotics.51 In the main, current prescrib-
ing patterns have improved in comparison with amoxicillin use in
26% of pneumonia cases in the Dutch general population in
2001.31
Only half of strep throat and tonsillitis cases in our study were
treated with recommended narrow-spectrum penicillins (phe-
nethicillin and phenoxymethylpenicillin). Previous paediatric stud-
ies highlighted similar problems of narrow-spectrum antibiotic
underuse (63% in the Netherlands and 67% in Norway).33,43
Again, this may be related to concerns about their limited activity,
and broad-spectrum penicillins or macrolides may have been pre-
scribed instead. Another factor for altered prescribing patterns
might be the (un)availability of phenethicillin on the Dutch
pharmaceutical market, which needs further confirmation. One
more explanation for using macrolides may be their administra-
tive convenience and preferential taste compared with the bitter-
tasting phenoxymethylpenicillin, which can affect medication
compliance in children.53
There were marked variations in antibiotic prescribing by prac-
tices in 2012, both for conditions that require antibiotics and for
those that do not, such as bronchitis. The variability in the propor-
tions prescribed antibiotics is broadly similar to the figures
reported by a UK analysis of a large database of primary care con-
sultations in 2011 (sore throat, 45%–78%; AOM, 63%–97%).20
Our findings about inter-practice variations in adherence are in
agreement with other reports in Dutch primary care over the past
decade.39,54 An earlier study also indicated greater variations
between general practices for first-choice antibiotics than for
restrictive antibiotic prescribing. Its authors suggested that the
quality of first-choice prescribing was more related to practice
characteristics, while the quality of restrictive prescribing was
more related to patient population characteristics. As suggested,
differences between practices might be attributed in part
to variations in diagnostic preferences and coding practices,
given the high diagnostic uncertainty of RTIs. Therefore, further
consultation-level analysis of practices and GPs’ characteristics
and patients’ demographic and clinical features can improve our
understanding of these variations and shape improvement
strategies.
Implications for research and practice
RTIs form a major component of GP workload, but they are made
challenging by diagnostic and prognostic uncertainties. Our
results indicate that most paediatric fever and ear and respiratory
infections in the Netherlands continue to be managed conserva-
tively, with relatively low use of antibiotics. These figures could be
used as indicators of attainable prescribing rates by other EU
countries with higher antibiotic consumption.
In the Dutch context, further improvement efforts need to
focus on reducing antibiotic use for acute bronchitis and increas-
ing the use of first-choice antibiotics, especially narrow-spectrum
penicillins. Progress may be achieved by targeting practices with
lower adherence rates to guidelines. Better-performing practices
may help develop suitable antibiotic indicators and set attainable
standards for benchmarking purposes.39 Near-patient testing and
communication skills training for GPs seem promising in man-
aging uncertainties for RTI treatment and dealing with patients’
concerns and pressure.55 New potential interventions suited to
the local situation can make use of the Dutch professionalized
and self-regulated peer group review system. During recent dec-
ades, this professional model has become a credible healthcare
policy instrument in improving formulary adherence and assuring
quality patient care.56,57 We recommend that the effects of
Ivanovska et al.
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guidelines are actively monitored when it comes to antibiotic util-
ization, adherence, changes in clinical disease patterns and com-
plication rates to demonstrate the benefits and safety of national
implementation of prescribing advice.
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